Clinical and Laboratory Studies with Tobramycin

Publisher Website
Google Scholar
Abstract
Tobramycin is a new amino-hexose antibiotic which is closely related to gentamicin. It is more active than gentamicin against Pseudomonas aeruginosa but has less antibacterial activity against other gram-negative bacilli. Absorption and excretion studies in human volunteers confirm satisfactory blood levels. 31 patients suffering from infections caused by gram-negative organisms, including 18 due to Ps. aeruginosa, have been treated with tobramycin and 28 responded clinically to the antibiotic. One patient developed signs of ototoxicity following treatment with tobramycin.

This publication has 0 references indexed in Scilit: